Our Promise

At GTC Consulting, we are dedicated to helping you navigate the complexities of controlled substance distribution with precision and confidence. Specializing in compliance with USC 823 (a-g) regulations, we aim to prevent costly disruptions within the pharmaceutical supply chain. Our comprehensive services include DEA compliance guidance, specialized support for opioid-related litigation, NABP VAWD/DDA accreditation consulting, regulatory oversight for clinical trials involving controlled substances, and expert advice on enhancing supply chain security.

Explore More

Award winning consultancy.

National Association of Drug Diversion Investigators (NADDI) Challenge Award

Drug Enforcement Administration (DEA) Certificate of Appreciation for Outstanding Contributions

Unites States Attorneys Office (USAO) Certificate of Appreciation for Outstanding Contributions

Top 100 Magazine "40 under 40"

International Forum on Advancements for Healthcare (IFAH) "Top 100 Leaders"

International Forum on Advancements for Healthcare (IFAH) "Top 50 Healthcare Company"

Testimonials

GTC Consulting

5.0

Based on 3 reviews

review us on

Kevin Forehand

18:26 15 Aug 24

They do great work!

Esquivel

17:23 15 Aug 24

GTC Consulting is a premier compliance firm that excels in all aspects of the pharmaceutical and DEA industry. Their expertise is unmatched, ensuring that clients not only meet but exceed the stringent regulatory standards required in this highly regulated sector. With a team of seasoned professionals, GTC Consulting offers comprehensive services that cover every facet of compliance, from regulatory audits to licensing, training, and policy development.

What sets GTC Consulting apart is their deep understanding of the pharmaceutical landscape, combined with an unwavering commitment to client success. They work closely with clients to tailor solutions that are both effective and efficient, ensuring that companies remain compliant while optimizing their operations. Their proactive approach helps clients stay ahead of potential regulatory issues, reducing risk and enhancing overall business performance.

Moreover, GTC Consulting's expertise in DEA compliance is particularly noteworthy. They are adept at navigating the complex requirements of controlled substance regulations, providing clients with the peace of mind that their operations are fully compliant with all DEA mandates. Their training programs are top-tier, equipping staff with the knowledge and skills needed to maintain compliance in a constantly evolving regulatory environment.

In addition to their technical expertise, GTC Consulting is known for their exceptional customer service. They are responsive, reliable, and always ready to assist with any compliance-related challenges that may arise. Their dedication to building long-term partnerships with clients is evident in the personalized attention they provide and the ongoing support they offer.

In summary, GTC Consulting is a top-tier compliance partner for any organization in the pharmaceutical and DEA industry. Their extensive experience, coupled with their commitment to excellence, makes them the go-to choice for companies seeking to ensure regulatory compliance and operational efficiency.

Mike Bleich

17:09 15 Aug 24

I speak from experience. Ben Mink is the best in the business. His knowledge with the process of Accreditation with the (NABP) is priceless. GTC is the way to go, his consulting is worth every penny. In my opinion, using another company may save you a little, however, bad advice will cost you a lot more .

"Move forward with confidence."

Our Promise

Stay in the Loop

Our Enhanced Services Include

KYC Inspections

Physical Security Support

Proper Disposal Support

Substance Licensing Support

SOM Consultation

DEA Program Development

Award winning consultancy.

Our team, your champions.

BENJAMIN F. MINK

JORGE JIMENEZ

DR. FRANK MINK

Testimonials

Our News & Updates

Why Stakeholders Should Engage Outside Experts for DEA Compliance & Anti-Diversion Reviews

How a Trump Administration Could Potentially Influence Pharmaceutical Regulations in 2025

The Ongoing Saga of Opioid Lawsuits: A Look at the Settlements and Their Impact